<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; fast</title>
	<atom:link href="http://www.tapanray.in/tag/fast/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Is Pharma Industry A Late Learner, Always?</title>
		<link>http://www.tapanray.in/is-pharma-industry-a-late-learner-always/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=is-pharma-industry-a-late-learner-always</link>
		<comments>http://www.tapanray.in/is-pharma-industry-a-late-learner-always/#comments</comments>
		<pubDate>Mon, 23 Dec 2019 00:00:49 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[centricity]]></category>
		<category><![CDATA[consumer]]></category>
		<category><![CDATA[Consumerism]]></category>
		<category><![CDATA[customer]]></category>
		<category><![CDATA[diagnosis]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[Digitalization]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[E-Patients]]></category>
		<category><![CDATA[empowerment]]></category>
		<category><![CDATA[end-to-end]]></category>
		<category><![CDATA[episodes]]></category>
		<category><![CDATA[experience]]></category>
		<category><![CDATA[factor]]></category>
		<category><![CDATA[fast]]></category>
		<category><![CDATA[Ferguson]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[late]]></category>
		<category><![CDATA[learner]]></category>
		<category><![CDATA[learning]]></category>
		<category><![CDATA[legacy]]></category>
		<category><![CDATA[organization]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[process]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reinvent the wheel]]></category>
		<category><![CDATA[solution]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[Thomas]]></category>
		<category><![CDATA[touchpoints]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9826</guid>
		<description><![CDATA[Several upcoming concepts in the pharmaceutical industry are becoming buzzwords today. But, most of these were recommended by stalwarts several decades ago. Interestingly, the prevailing scenario is no different, even related to wide-scale adoption of a number of cutting-edge technologies, &#8230; <a href="http://www.tapanray.in/is-pharma-industry-a-late-learner-always/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/is-pharma-industry-a-late-learner-always/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The domestic API players are fast losing their dominance in the Indian API market</title>
		<link>http://www.tapanray.in/the-domestic-api-players-are-fast-losing-their-dominance-in-the-indian-api-market/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-domestic-api-players-are-fast-losing-their-dominance-in-the-indian-api-market</link>
		<comments>http://www.tapanray.in/the-domestic-api-players-are-fast-losing-their-dominance-in-the-indian-api-market/#comments</comments>
		<pubDate>Mon, 24 Oct 2011 00:30:20 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Active]]></category>
		<category><![CDATA[API]]></category>
		<category><![CDATA[are]]></category>
		<category><![CDATA[bulk]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[DMF]]></category>
		<category><![CDATA[domestic]]></category>
		<category><![CDATA[dominance]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[fast]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[ingredients]]></category>
		<category><![CDATA[losing]]></category>
		<category><![CDATA[market]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Players]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[their]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=184</guid>
		<description><![CDATA[There are two broad categories of markets for the Active Pharmaceutical Ingredients (API) across the world namely, highly regulated and semi regulated markets. Countries like, USA, Europe and Japan will fall under highly regulated category with high entry barriers for &#8230; <a href="http://www.tapanray.in/the-domestic-api-players-are-fast-losing-their-dominance-in-the-indian-api-market/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-domestic-api-players-are-fast-losing-their-dominance-in-the-indian-api-market/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>‘Medical Outsourcing’ – a fast evolving area in the healthcare space with high business potential.</title>
		<link>http://www.tapanray.in/medical-outsourcing-a-fast-evolving-area-in-the-healthcare-space-with-high-business-potential/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=medical-outsourcing-a-fast-evolving-area-in-the-healthcare-space-with-high-business-potential</link>
		<comments>http://www.tapanray.in/medical-outsourcing-a-fast-evolving-area-in-the-healthcare-space-with-high-business-potential/#comments</comments>
		<pubDate>Mon, 12 Oct 2009 01:30:48 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[area]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[doctors]]></category>
		<category><![CDATA[evolving]]></category>
		<category><![CDATA[fast]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[high]]></category>
		<category><![CDATA[hospitals]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[insurance]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[nurses]]></category>
		<category><![CDATA[outsourcing]]></category>
		<category><![CDATA[payors]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[potential]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Space]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[USA]]></category>
		<category><![CDATA[with]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=757</guid>
		<description><![CDATA[Medical outsourcing is an evolving area in the global healthcare space. It can offer immense opportunity to India, if explored appropriatly with a carefully worked out strategic game plan from the very nascent stage of its evolution process. This sector &#8230; <a href="http://www.tapanray.in/medical-outsourcing-a-fast-evolving-area-in-the-healthcare-space-with-high-business-potential/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/medical-outsourcing-a-fast-evolving-area-in-the-healthcare-space-with-high-business-potential/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biosimilars –Indian Pharmaceutical Companies are sharpening their focus on fast growing Oncology segment</title>
		<link>http://www.tapanray.in/biosimilars-indian-pharmaceutical-companies-are-sharpening-their-focus-on-fast-growing-oncology-segment/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=biosimilars-indian-pharmaceutical-companies-are-sharpening-their-focus-on-fast-growing-oncology-segment</link>
		<comments>http://www.tapanray.in/biosimilars-indian-pharmaceutical-companies-are-sharpening-their-focus-on-fast-growing-oncology-segment/#comments</comments>
		<pubDate>Mon, 13 Jul 2009 01:30:51 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[are]]></category>
		<category><![CDATA[biosimilars]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[fast]]></category>
		<category><![CDATA[focus]]></category>
		<category><![CDATA[Growing]]></category>
		<category><![CDATA[Guidelines]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[on]]></category>
		<category><![CDATA[oncology]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[segment]]></category>
		<category><![CDATA[sharpening]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[their]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=836</guid>
		<description><![CDATA[The global market for Bio-pharmaceuticals is estimated to be around US$ 50 billion by the next year. Currently about 25% of New Molecular Entities (NMEs) under development are of biotech origin. Indian pharmaceutical majors like Dr. Reddy’s Laboratories (DRL), Reliance &#8230; <a href="http://www.tapanray.in/biosimilars-indian-pharmaceutical-companies-are-sharpening-their-focus-on-fast-growing-oncology-segment/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/biosimilars-indian-pharmaceutical-companies-are-sharpening-their-focus-on-fast-growing-oncology-segment/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
